Kristina Lamberg
Uppsala University Hospital(SE)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, RNA modifications and cancer, Cancer Genomics and Diagnostics
Most-Cited Works
- Effect of delays on prognosis in patients with non-small cell lung cancer.(2004)
- → Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group(2005)215 cited
- → α-2b interferon and oral clodronate for Gorham's disease(1997)122 cited
- → CD99 is a novel prognostic stromal marker in non‐small cell lung cancer(2012)86 cited
- → Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients(2002)68 cited
- → Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group(2011)61 cited
- Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum.(1998)
- → Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer(2011)53 cited
- → Regional differences in treatment and outcome in non-small cell lung cancer: A population-based study (Sweden)(2008)46 cited
- → Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program(2021)44 cited